Advanced Pharmacotherapeutics in Cardiovascular Diseases
Postgraduate
TAS-CSA722 2025Course information for 2025 intake View information for 2024 course intake
- Study method
- 100% online
- Assessments
- 100% online
- Enrol by
- 16 Feb 2025
- Entry requirements
- Part of a degree
- Duration
- 14 weeks
- Price from
- $2,726
- Upfront cost
- $0
- Loan available
- HECS-HELP and FEE-HELP available
Advanced Pharmacotherapeutics in Cardiovascular Diseases
About this subject
Upon successful completion of this subject, the student should be able to:
- Create a search strategy to collate evidence-based cardiovascular related research.
- Evaluate cardiovascular medication therapy using an evidence-based approach.
- Apply evidence-based and contemporary clinical skills in the management of cardiovascular disease.
- Interpret and transmit knowledge, skills and ideas to specialist and non-specialist audiences.
- Refer to MyLO for study topics
TAS-CSA722 is a self-directed, fully online subject, that explores a variety of disease states and their management, using a series of patient cases linked to assignment-based questions, to enable you to enhance your knowledge in clinical pharmacy and pharmaceutical care. This subject covers the medication management and clinical pharmacy issues in cardiovascular diseases.
- Presentation (25%)
- Evidence-Based Practice Assignment (10%)
- Application of Structured EBM to Patient Care (25%)
- Specific Clinical Questions related to a Clinical Case (40%)
For textbook details check your university's handbook, website or learning management system (LMS).
Wherever you are, the University of Tasmania brings its island campus to you through a growing range of online programs across art and design, business, education, health, science, sustainability, technology, and more. It’s never too late to switch things up. Kickstart that career you’ve been dreaming about, or upskill for the one you’re in. You’ll also become a part of the world's leading university on climate action.
Learn more about UTAS.
Explore UTAS courses.
- QS Ranking 2024:
- 20
- Times Higher Education Ranking 2024:
- 19
Entry requirements
Part of a degree
To enrol in this subject you must be accepted into one of the following degrees:
Elective
- TAS-CPH-GDI-2025 - Graduate Diploma of Clinical Pharmacy
- TAS-CPH-GCE-2025 - Graduate Certificate in Clinical Pharmacy
Prior study
You must either have successfully completed the following subject(s) before starting this subject, or enrol in the following subject(s) to study at the same time or prior to this subject:
one of
TAS-CSA721-Introduction to Advanced Clinical Pharmacy Practice (no longer available)
- TAS-CSA731-Evidence Based Pharmacotherapeutic Practice
Additional requirements
No additional requirements
Study load
- 0.125 EFTSL
- This is in the range of 10 to 12 hours of study each week.
Equivalent full time study load (EFTSL) is one way to calculate your study load. One (1.0) EFTSL is equivalent to a full-time study load for one year.
Find out more information on Commonwealth Loans to understand what this means to your eligibility for financial support.
Related degrees
Once you’ve completed this subject it can be credited towards one of the following courses
Graduate Diploma of Clinical Pharmacy
Postgraduate
TAS-CPH-GDIGraduate Certificate in Clinical Pharmacy
Postgraduate
TAS-CPH-GCE